A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia
about
A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Phase I/II, Open-label Study ...... h Chronic Lymphocytic Leukemia
@en
type
label
A Phase I/II, Open-label Study ...... h Chronic Lymphocytic Leukemia
@en
prefLabel
A Phase I/II, Open-label Study ...... h Chronic Lymphocytic Leukemia
@en
P1050
P1476
A Phase I/II, Open-label Study ...... h Chronic Lymphocytic Leukemia
@en
P17
P3098
NCT01563055
P580
2012-04-01T00:00:00Z
P582
2014-11-01T00:00:00Z